ImpriMed will be exhibiting at ASH to showcase our AI-driven precision medicine platform for hematologic malignancies. Visit our booth #226 to learn how our ex vivo drug sensitivity testing and predictive analytics generate patient-specific insights to help guide treatment decisions.
Click here to go to the official event page →ImpriMed will be exhibiting at ASH to showcase our AI-driven precision medicine platform for hematologic malignancies. Visit our booth #226 to learn how our ex vivo drug sensitivity testing and predictive analytics generate patient-specific insights to help guide treatment decisions.
